Condition: Lupus Nephritis · Sponsor: Institutul Clinic Fundeni
The aim of the study is to evaluate the efficacy of a therapeutic regimen which decreases glucocorticoid exposure compared with standard therapy in patients with proliferative lupus nephritis during remission induction by evaluating the histological and clinical remission.
This description comes directly from the study's public registry record.
Bogdan Obrisca, MD, PhD · 0040721256797 · obriscabogdan@yahoo.com
Alexandra Vornicu, MD · 0040756203773 · vornicu.alexandra@yahoo.com
Always discuss trial participation with your own doctor first.
| Fundeni Clinical Institute | Bucharest, Romania | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05207358